Skip to main navigation Skip to search Skip to main content

Use of amylin agonists in the treatment of diabetes mellitus

    Research output: Patent

    Original languageEnglish
    Patent numberCA1341060
    Publication statusPublished - 25 Jul 2000

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this